An Integrative Bioinformatics Approach to Investigating TIMP3 and Immune Cell Infiltration: Prognostic and...

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Tissue inhibitor of metalloproteinase 3 (TIMP3) is an endogenous inhibitor of matrix metalloproteinases (MMPs) involved in metastasis and angiogenesis.
• The specific role of TIMP3 in colorectal cancer (CRC) progression and its impact on the tumor microenvironment (TME) are not fully understood.

Purpose of the Study:

• To investigate the prognostic significance of TIMP3 in CRC using a comprehensive bioinformatic analysis.
• To explore the association of TIMP3 with cancer hallmarks, immune cell infiltration, and immunotherapeutic responses in CRC.

Main Methods:

• Utilized multiple bioinformatic databases (GEPIA, UALCAN, Kaplan-Meier plotter, etc.) for differential expression, prognostic, and pathway analysis.
• Assessed TIMP3's correlation with immune cell infiltration, TME components, and immunotherapeutic markers (PD-1/PD-L1).

Main Results:

• TIMP3 expression was significantly downregulated in CRC tissues compared to normal tissues.
• TIMP3 downregulation was linked to extracellular matrix organization and angiogenesis, crucial in CRC progression.
• TIMP3 levels correlated with immune cell infiltration (B cells, T cells, macrophages, etc.) and improved immunotherapeutic responses.

Conclusions:

• TIMP3 plays a multifaceted role in CRC, influencing both cancer progression pathways and the immune microenvironment.
• Downregulation of TIMP3 significantly impacts the CRC immune landscape, suggesting its potential as a prognostic biomarker and therapeutic target.